2021
DOI: 10.1016/j.ejphar.2021.174219
|View full text |Cite
|
Sign up to set email alerts
|

HO-1: A new potential therapeutic target to combat osteoporosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 108 publications
0
16
0
Order By: Relevance
“…Withdrawal estrogen increased CCR2, CCL7, and CCL2 expression but reduced PMOP in mice after inhibition of CCL7 and CCL2 synthesis by administration of band [ 39 ]. Hmox1 (HO-1) has been identified as a new potential therapeutic target against OP [ 40 , 41 ]. TBX21 gene is a T-box expressed in T cells.…”
Section: Discussionmentioning
confidence: 99%
“…Withdrawal estrogen increased CCR2, CCL7, and CCL2 expression but reduced PMOP in mice after inhibition of CCL7 and CCL2 synthesis by administration of band [ 39 ]. Hmox1 (HO-1) has been identified as a new potential therapeutic target against OP [ 40 , 41 ]. TBX21 gene is a T-box expressed in T cells.…”
Section: Discussionmentioning
confidence: 99%
“…Mitochondria is the center of REDOX balance in cells, and excess ferrous iron catalyzes the ROS generation through the Fenton reaction to disturb the REDOX balance. Excess ROS induces the apoptosis of osteoblasts by inhibiting various signaling pathways, such as Wnt/β-catenin signaling and FoxOs-mediated transcription ( 40 , 41 ). Following, we evaluated some markers of REDOX balance, including ROS levels, MDA content, SOD content and GSH content.…”
Section: Resultsmentioning
confidence: 99%
“…The crucial finding is that TAP treatment over-expresses the inducible isoform of heme oxygenase (HMOX1), a well-established immunomodulator [ 65 , 66 , 67 ]; it has been proven that the induction of HMOX1 protects against the cytotoxicity caused by oxidative stress and apoptotic cell death, making HMOX1 an appealing target for the treatment of several chronic inflammatory diseases, including osteoporosis [ 68 ], cancer [ 69 ], acute kidney injury [ 70 ], retinal pigment epithelium degeneration [ 71 ] and Parkinson’s disease [ 56 , 67 ].…”
Section: Discussionmentioning
confidence: 99%